IV Chelation
Chelation therapy is an intravenous treatment used to rid the body of potentially deadly toxins, to restore good circulation to all of the bodily tissues, and to remove or reduce the amount of debris along the arterial walls. It has been proven to effectively treat atherosclerosis (hardening of the arteries) and gangrene, and can dramatically improve the quality of life for patients with arthritis, lupus, scleroderma, and failing memories. A mildly acidic substance called ethylenediaminetetraacetic acid (EDTA) is added to the bloodstream to
break down metastatic calcium and mobilize heavy metals for excretion through the kidneys. A chelation treatment, or infusion, takes between two and three hours, during which the patient is asked to rest comfortably. The treatments themselves are painless and there are almost no reported side effects. The number of treatments required depends on the patient’s initial condition and how well his or her body responds to the infusions.
Since the 1960’s, almost one million North Americans have been treated with chelation therapy, but government regulators have yet to approve the use of EDTA for anything other than reducing heavy metal toxicity. The amount of EDTA used in each infusion treatment is said to be less toxic than taking one aspirin tablet. Some researchers have asserted that if chelation were to be adopted as a standard medical practice for reducing arterial plaque, nearly 85% of coronary bypass surgeries could be avoided.
